Latest in News & Research
Can Adalimumab Improve Hematologic Abnormalities in Hidradenitis Suppurativa?
Greater improvements seen in hematologic abnormalities for patients with clinical response to adalimumab
Melanoma Monday: Transforming Lives Through Early Detection and Prevention
The first Monday in May is Melanoma Monday—explore its role in advancing public health and how dermatologists can spread its message to their patients
LAUNCH ALERT: SPEVIGO expanded indications now available in the US
The US FDA’s expanded approval makes SPEVIGO the first targeted therapy that addresses the need for acute and chronic treatment for patients with GPP.
International Consensus Achieved for Generalized Pustular Psoriasis
Final definition is 'systemic inflammatory disease characterized by cutaneous erythema and macroscopically visible sterile pustules'
Increase Seen in Melanoma Incidence With No Increase in Mortality
Subsequent increase seen for men, no change for women; no temporal trends in mortality noted during 1999 to 2019
Stigma Affects Quality of Life in Children With Chronic Skin Conditions
Stigma correlates with depression and differs based on level of severity and visibility
Tobacco Smoking Reduces the Odds of Psoriasis Improvement
Achievement of ≥75 percent reduction in Psoriasis Area and Severity Index lower in both current, former smokers
Dupilumab Safe, Effective Over Long Term for Atopic Dermatitis
Improvements seen in patient-reported outcome measures, including Patient-Oriented Eczema Measure, Dermatology Life Quality Index
Facial Skin Cancer Surgery Does Not Influence Quality of Life
Low scores seen for perceived stigmatization and body image concerns; satisfaction with facial appearance, psychological distress improved
Atopic Dermatitis Negatively Impacts Mental Health
Greater negative impact seen among patients with severe atopic dermatitis
Review Explores Cutaneous Manifestations of Myelodysplastic Syndrome
Common manifestations include neutrophilic dermatoses, vasculitis, granulomatous, connective tissue disease
Erenumab Effective, Safe for Rosacea-Linked Erythema, Flushing
Reduction seen in mean number of days with moderate-to-extreme flushing, moderate-to-severe erythema
Once-Weekly Pulsed Dye Laser Beneficial for Port-Wine Birthmarks
Seven of 10 infants had near-total or total clearance after two months with once-weekly treatments
Best Results for Classifying Malignant Melanoma Seen When Clinicians Work With AI
Less heterogeneity in sensitivity, specificity, accuracy seen when clinicians worked in unison with artificial intelligence
CDC Warns of 19 Cases of Botched Botox Shots in 9 States
FDA Approves New Antibiotic for Three Indications
Zevtera approved for S. aureus bloodstream infections, acute bacterial skin/skin structure infections, and bacterial pneumonia
Bioactive Retinol Efficacious for Improving Signs of Photoaging
Improvement seen in all signs of photoaging as early as week 4 and through 12 weeks, with no major irritation
Study Identifies Factors That Affect Antibiotic Prescribing for Acne
Five themes affect long-term prescribing, including perceived lack of evidence to justify change, discomfort discussing contraception
Low Adherence to Follow-Up Seen for Primary Invasive Melanoma
Greater adherence to annual dermatology visits leads to reduced melanoma-specific mortality
Oral Minoxidil Not Superior to Topical for Male Androgenetic Alopecia
Oral minoxidil can be an option for patients who would rather take an oral therapy or cannot tolerate topical treatment
High-Strength Lidocaine Skin Creams Can Cause Seizures, Heart Trouble, FDA Warns
Model, Nomogram Predict Recurrence-Free, Melanoma-Specific Survival
Final model composed of six prognostic factors showed good prediction in development cohort and external validation
Tildrakizumab Efficacious, Safe for Plaque Psoriasis of the Scalp
Significant improvement seen in IGA response and PSSI 90, with no serious treatment-related adverse events
24 of 1244